ATF4 and inflammatory bowel disease: Noteworthy, alterations in the trafficking behavior and membrane lipid composition in DSS-treated cells are closely linked to the increased expression of ATF4 and CHOP, which are, in turn, activators of the pro-inflammatory cytokine TNF-α [34,35], which is directly implicated in the pathogenesis of IBD.